DR. REBECCA B CAMPEN MD NPI 1023086899

NPI Details

DR. Rebecca B Campen, MD is a dermatology in Savannah, GA with 38 years of experience. The provider is a dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging. DR. Rebecca B Campen, MD NPI is 1023086899. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: MEDICAL COLLEGE OF GEORGIA SCHOOL OF MEDICINE
Graduation Year:1987

The provider's business location address is:

5102 PAULSEN ST
BLDG 4
SAVANNAH, GA
ZIP 31405-601
Phone: (912) 356-3604
Fax: (912) 356-5801

The NPI 1023086899 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Biopsy of related skin growth, first growth (HCPCS:11102)
• Destruction of skin growth, 1-14 growths (HCPCS:17110)
• Biopsy of related skin growth, each additional growth (HCPCS:11103)
• Destruction of precancer skin growth, 15 or more growths (HCPCS:17004)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Destruction of skin growth, 15 or more growths (HCPCS:17111)
• Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm (HCPCS:12032)
• Biopsy of ear (HCPCS:69100)
• Removal of cancer skin growth of body, arms, or legs, more than 4.0 cm (HCPCS:11606)
• Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) (HCPCS:J7308)
• Application of light by qualified health care professional to destroy precancer skin growth (HCPCS:96573)
• Punch biopsy, first skin growth (HCPCS:11104)
• All potassium hydroxide (koh) preparations (HCPCS:Q0112)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Simple or single drainage of skin abscess (HCPCS:10060)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection into skin growth, 1-7 growths (HCPCS:11900)
• Removal of noncancer skin growth of body, arms, or legs, 3.1-4.0 cm (HCPCS:11404)
• Removal of cancer skin growth of body, arms, or legs, 3.1-4.0 cm (HCPCS:11604)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 3/9/2006 and was last updated on 3/26/2010.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.